The Australian and New Zealand governments have reportedly developed a five-year plan to create a joint agency that will regulate medicines, medical devices and new medical interventions, such as cellular therapy. In a statement announcing the initiative, New Zealand Prime Minister John Key said, “We want to move into a situation where all medicines and medical devices are specifically approved for New Zealanders before they are used. Currently, medicines are subject to this approval but medical devices are listed on a notification database which should be improved—the establishment of this new agency provides the opportunity to do so.” The agency, to be called the Australia New Zealand Therapeutic Products Agency, could include oversight of natural health products in addition to conventional therapies, although creation of the joint agency does not depend on whether these products are ultimately placed under its umbrella, according to Key. See PM John Key Press Release, June 20, 2011; MassDevice, June 22, 2011.